Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals KNSA Stock

$94.97   -0.147197%
Add to favorites
Market Cap
$7.46B
LOW - HIGH [24H]
$94.75 - $97.01
VOLUME [24H]
$129.85K
P/E Ratio
71.94
Earnings per share
$1.32
ISIN
GB00BRXB0C07
Price   Prediction

Kiniksa Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

Kiniksa Pharmaceuticals (KNSA) stock price today is 94.97 USD on Tech Market Large (-0.15% on the day). Updated .

Kiniksa Pharmaceuticals KNSA Financial and Trading Overview

Kiniksa Pharmaceuticals stock price 94.97 USD
Previous Close 94.23 USD
Open 94.23 USD
Bid 69.1 USD x 200
Ask 120.61 USD x 200
Day's Range 93.29 - 95.7 USD
52 Week Range 37.02 - 99.31 USD
Volume 387.74K USD
Avg. Volume 670.59K USD
Market Cap 7.47B USD
Beta (5Y Monthly) 0.083
PE Ratio (TTM) 72.053024
EPS (TTM) 1.32 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 111.57 USD

KNSA Valuation Measures

Enterprise Value 6.91B USD
Trailing P/E 72.053024
Forward P/E 46.508556
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.8998384
Price/Book (mrq) 10.510554
Enterprise Value/Revenue 7.307
Enterprise Value/EBITDA 52.221

Trading Information

Kiniksa Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.083
52-Week Change 125.59%
S&P500 52-Week Change 10.51%
52 Week High 99.31 USD
52 Week Low 37.02 USD
50-Day Moving Average 82.86 USD
200-Day Moving Average 63.33 USD

KNSA Share Statistics

Avg. Volume (3 month) 670.59K USD
Avg. Daily Volume (10-Days) 614.18K USD
Shares Outstanding 48.84M
Float 40.61M
Short Ratio 5.13
% Held by Insiders 3.45%
% Held by Institutions 100.68%
Shares Short 4.29M
Short % of Float 10.60%
Short % of Shares Outstanding 5.46%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 11.58%
Operating Margin (ttm) 13.79%
Gross Margin 54.27%
EBITDA Margin 13.99%

Management Effectiveness

Return on Assets (ttm) 9.61%
Return on Equity (ttm) 17.59%

Income Statement

Revenue (ttm) 945.96M USD
Revenue Per Share (ttm) 12.27 USD
Quarterly Revenue Growth (yoy) 58.09%
Gross Profit (ttm) 513.39M USD
EBITDA 132.36M USD
Net Income Avi to Common (ttm) 109.57M USD
Diluted EPS (ttm) 1.32
Quarterly Earnings Growth (yoy) 156.80%

Balance Sheet

Total Cash (mrq) 568.76M USD
Total Cash Per Share (mrq) 7.24 USD
Total Debt (mrq) 7.88M USD
Total Debt/Equity (mrq) 1.11 USD
Current Ratio (mrq) 3.91
Book Value Per Share (mrq) 9.049

Cash Flow Statement

Operating Cash Flow (ttm) 198.84M USD
Levered Free Cash Flow (ttm) 135.87M USD

Profile of Kiniksa Pharmaceuticals

Country United States
State N/A
City London
Address 105 Piccadilly
ZIP W1J 7NJ
Phone 44 78 1431 9100
Website https://www.kiniksa.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 366

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.

Q&A For Kiniksa Pharmaceuticals Stock

What is a current KNSA stock price?

Kiniksa Pharmaceuticals KNSA stock price today per share is 94.97 USD.

How to purchase Kiniksa Pharmaceuticals stock?

You can buy KNSA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Kiniksa Pharmaceuticals?

The stock symbol or ticker of Kiniksa Pharmaceuticals is KNSA.

Which industry does the Kiniksa Pharmaceuticals company belong to?

The Kiniksa Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.

How many shares does Kiniksa Pharmaceuticals have in circulation?

The max supply of Kiniksa Pharmaceuticals shares is 78.57M.

What is Kiniksa Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Kiniksa Pharmaceuticals PE Ratio is 71.94697000 now.

What was Kiniksa Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Kiniksa Pharmaceuticals EPS is 1.32 USD over the trailing 12 months.

Which sector does the Kiniksa Pharmaceuticals company belong to?

The Kiniksa Pharmaceuticals sector is Healthcare.

Kiniksa Pharmaceuticals KNSA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24447.41 USD —
+0.49
4.72B USD — 24225.3 USD — 24538.78 USD — — 4.72B USD —
us US Tech Global Select Market Com NQGS US 11980.52 USD —
-0.03
— — 11954.49 USD — 12087.35 USD — — — —
us US Tech Biotechnology NBI US 6971.04 USD —
-0.67
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1324.94 USD —
-0.6
— — 1322.85 USD — 1342.46 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.16T
Total marketcap
$71.14B
Total volume
BTC 58.04%   •   ETH 9.89%
Dominance
Select currency